Table 6. Adjusted hazard ratio for PFS and OS in NSCLC patients.
| PFS | OS | ||||||
| HR | 95%CI | P | HR | 95%CI | P | ||
| 82G/S polymorphism | 82GG | 1 | 1 | ||||
| 82GS+82SS | 1.73 | 1.13–2.58 | 0.003 | 2.34 | 1.93–3.94 | <0.001 | |
| Chemotherapy responder | Non-Responder | 1 | |||||
| Responder | 5.23 | 2.76–7.98 | <0.001 | 4.32 | 2.56–8.46 | <0.001 | |
| Smoke | Non-smoker | 1 | |||||
| Smoker | 1.67 | 1.32–3.01 | 0.036 | 2.45 | 2.15–4.17 | 0.002 | |
| Cancer stage | III | 1 | |||||
| IV | 1.98 | 1.15–3.05 | 0.027 | 2.18 | 1.78–3.31 | 0.003 |